High-Density Lipoprotein (HDL) From Elderly and Reconstituted HDL Containing Glycated Apolipoproteins A-I Share Proatherosclerotic and Prosenescent Properties With Increased Cholesterol Influx
Authors:
Open Access
- 17 March 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 66A (5) , 511-520
Abstract
High-density lipoprotein (HDL) is a strong antioxidant, anti-inflammatory, and antisenescence molecule. However, in the current study, HDL from the elderly group (E-HDL) exhibited increased glycation with apolipoprotein (apo) A-I multimerization and decreased phospholipid content. Similarly, glycated apoA-I (gA-I) by fructosylation has a covalently multimerized band without a crosslinker and impaired phospholipid-binding ability. Treatment of human dermal fibroblasts and macrophages with E-HDL and gA-I caused more severe cellular senescence and foam cell formation, respectively; however, treatment with HDL from a young group (Y-HDL) and native apoA-I (nA-I) suppressed senescence and atherosclerosis. E-HDL3 and reconstituted HDL (rHDL) containing gA-I showed enhanced cholesterol influx into macrophages compared with Y-HDL3 and nA-I-rHDL. In conclusion, E-HDL and gA-I-rHDL share similar physiologic properties in macrophages and human dermal fibroblasts. E-HDL and gA-I-rHDL exacerbated cellular senescence and atherosclerosis with increased cellular cholesterol influx.Keywords
This publication has 38 references indexed in Scilit:
- Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescenceBiochemical and Biophysical Research Communications, 2010
- Dietary Fructose and Metabolic Syndrome and DiabetesThe Journal of Nutrition, 2009
- Synthesis of Reconstituted High Density Lipoprotein (rHDL) Containing apoA-I and apoC-III: the Functional Role of apoC-III in rHDLMolecules and Cells, 2009
- Myocardial infarction patients show altered lipoprotein properties and functions when compared with stable angina pectoris patientsExperimental & Molecular Medicine, 2009
- Induction of Cellular Senescence by Insulin-like Growth Factor Binding Protein-5 through a p53-dependent MechanismMolecular Biology of the Cell, 2007
- Invited Commentary: Lipoproteins and Dementia--Is It the Apolipoprotein A-I?American Journal of Epidemiology, 2007
- Beyond CholesterolNew England Journal of Medicine, 1989
- Non enzymatic glycation of apolipoprotein A-I. Effects on its self-association and lipid binding propertiesBiochemical and Biophysical Research Communications, 1988
- Abnormal interaction of the human apolipoprotein A-I variant [Lys107→0] with high density lipoproteinsBiochemical and Biophysical Research Communications, 1985
- Plasma apolipoproteins AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjectsDiabetes, 1985